Cargando…

Trastuzumab cardiotoxiciy: the age-old balance of risk and benefit

Detalles Bibliográficos
Autores principales:	Ewer, Michael S, Ewer, Steven M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155370/ https://www.ncbi.nlm.nih.gov/pubmed/27875521 http://dx.doi.org/10.1038/bjc.2016.381

Ejemplares similares

Perspective on the Cardiotoxicity of Third-Generation Targeted EGFRs in the Treatment of NSCLC
por: Ewer, Michael S., et al.
Publicado: (2021)

Pulse Oximetry Screening for Critical Congenital Heart Defects: A Life-Saving Test for All Newborn Babies
por: Ewer, Andrew K.
Publicado: (2019)

Balancing risk and benefit during coronavirus
por: Sehn, Laurie H.
Publicado: (2020)

Balancing risks and benefits of artificial intelligence in the health sector
por: Goodman, Kenneth, et al.
Publicado: (2020)

Neurosurgical innovation: balancing the risks and benefits of technical novelty
por: Cohen-Gadol, Aaron A.
Publicado: (2019)

Benefit-risk balance of COVID drugs. New prospects
por: Cracowski, Jean-Luc, et al.
Publicado: (2022)

How the Ecdysozoan Changed Its Coat
por: Ewer, John
Publicado: (2005)

Some Account of the Medicinal Properties of a Bark Lately Procured from South America
por: Ewer, J.
Publicado: (1789)

Balancing the risks and benefits of biologic drugs in rheumatic disease: the case for romosozumab?
por: Reid, David M.
Publicado: (2020)

BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer
por: Dang, Chau, et al.
Publicado: (2022)

Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports
por: Ewer, Michael S., et al.
Publicado: (2022)

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?
por: Ewer, Michael S., et al.
Publicado: (2016)

Balancing gastrointestinal benefit–risk in individuals who are prescribed NSAIDs for arthritis
por: Bijlsma, Johannes W. J.
Publicado: (2010)

Balancing Benefits and Risks: Do Inhaled Corticosteroids Modify the Lung Microbiome?
por: Singh, Shivani, et al.
Publicado: (2021)

Preventive Medicine
por: Ewer, T.K.
Publicado: (1982)

The complete idiot's guide to getting organized
por: Ewer, Cynthia Townley
Publicado: (2012)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Potential and Pitfalls of Pharmacovigilance Databases in Oncology
por: Schlam, Ilana, et al.
Publicado: (2023)

Balancing the benefits and harms of radiotherapy post-radical prostatectomy
por: Lamb, Benjamin W., et al.
Publicado: (2018)

Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
por: Triulzi, Tiziana, et al.
Publicado: (2018)

Calcium and cAMP directly modulate the speed of the Drosophila circadian clock
por: Palacios-Muñoz, Angelina, et al.
Publicado: (2018)

Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man
por: Flaxman, Amy, et al.
Publicado: (2018)

Reciprocal Relationship Between Calcium Signaling and Circadian Clocks: Implications for Calcium Homeostasis, Clock Function, and Therapeutics
por: Cavieres-Lepe, Javier, et al.
Publicado: (2021)

Trastuzumab and ECG Changes Dilemma
por: Alizadehasl, Azin, et al.
Publicado: (2023)

Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation
por: Rahman, Atiar M, et al.
Publicado: (2007)

Balancing the Risks and Benefits of Long‐Term Antiplatelet Therapies for Cardiovascular Disease: Clinical, Research, and Regulatory Implications
por: Alfredsson, Joakim, et al.
Publicado: (2015)

Whole colonic EUS with use of a novel device: in vivo animal study
por: Farhadi, Ashkan, et al.
Publicado: (2016)

Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
por: Fanta, Lauren E., et al.
Publicado: (2022)

Intra-procedural anticoagulation protocols for left-sided cardiac ablations: Striking a balance between risk and benefit
por: Siontis, Konstantinos C.
Publicado: (2016)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
por: Lambe, Teresa, et al.
Publicado: (2017)

Trastuzumab: a cardiologist’s perspective
por: Côté, Marc André
Publicado: (2008)

Cardiac safety of afatinib: a review of data from clinical trials
por: Ewer, Michael S., et al.
Publicado: (2015)

An Age-Old Problem
por: Katsanis, Nicholas, et al.
Publicado: (2007)

Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
por: Eiger, Daniel, et al.
Publicado: (2020)

Stereotyped responses of Drosophila peptidergic neuronal ensemble depend on downstream neuromodulators
por: Mena, Wilson, et al.
Publicado: (2016)

Extracting temporal relationships between weakly coupled peptidergic and motoneuronal signaling: Application to Drosophila ecdysis behavior
por: Piñeiro, Miguel, et al.
Publicado: (2021)

An overview of a different type of cardio-oncology gathering: summary of the COMP (cardio-oncology multidisciplinary practice) meeting held in Houston Texas, January 2020
por: Fadol, Anecita P., et al.
Publicado: (2020)

Cardiac Safety of Osimertinib: A Review of Data
por: Ewer, Michael S., et al.
Publicado: (2021)

Editorial: Case reports in cardio-oncology: 2022
por: Ewer, Michael S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ol9f1cl3f57i1bvhpavdrm7brv